| 1 | elderly | 12,925 |
| 2 | elder | 149 |
| 3 | tamoxifen-treated | 54 |
| 4 | superobese | 35 |
| 5 | octogenarian | 27 |
| 6 | biomarker-positive | 26 |
| 7 | oldest-old | 24 |
| 8 | cyp2c9*1/*3 | 21 |
| 9 | 1905 | 20 |
| 10 | quetiapine-treated | 17 |
| 11 | fe-scz | 15 |
| 12 | loracarbef-treated | 15 |
| 13 | vka-naive | 15 |
| 14 | non-svr | 13 |
| 15 | 7788 | 11 |
| 16 | acei-treated | 11 |
| 17 | 5010 | 10 |
| 18 | cefixime-treated | 10 |
| 19 | claudicant | 10 |
| 20 | hiv/tuberculosis | 10 |
| 21 | macau | 10 |
| 22 | milnacipran-treated | 10 |
| 23 | risedronate-treated | 10 |
| 24 | 6632 | 9 |
| 25 | efficacy-valid | 9 |
| 26 | hyperfiltering | 9 |
| 27 | iron-treated | 9 |
| 28 | parkfit | 9 |
| 29 | rfviia-treated | 9 |
| 30 | streptokinase-treated | 9 |
| 31 | treatment-adherent | 9 |
| 32 | efficacy-evaluable | 8 |
| 33 | multitrauma | 8 |
| 34 | stdrx | 8 |
| 35 | 1,414 | 7 |
| 36 | 1757 | 7 |
| 37 | 2636 | 7 |
| 38 | 3117 | 7 |
| 39 | adenosine-treated | 7 |
| 40 | arten | 7 |
| 41 | glucosafe | 7 |
| 42 | immuno-competent | 7 |
| 43 | nonpaced | 7 |
| 44 | ofloxacin-treated | 7 |
| 45 | polydipsic | 7 |
| 46 | post-menarchal | 7 |
| 47 | response-evaluable | 7 |
| 48 | rmd+ | 7 |
| 49 | vpa-treated | 7 |
| 50 | zaïre | 7 |
| 51 | 2,708 | 6 |
| 52 | briakinumab-treated | 6 |
| 53 | brunei | 6 |
| 54 | cimetidine-treated | 6 |
| 55 | clomipramine-treated | 6 |
| 56 | dislipidemic | 6 |
| 57 | experimental-group | 6 |
| 58 | pediatric/adolescent | 6 |
| 59 | shangaans | 6 |
| 60 | tx/is | 6 |
| 61 | 4888 | 5 |
| 62 | 6797 | 5 |
| 63 | acarbose-treated | 5 |
| 64 | acrf | 5 |
| 65 | amusic | 5 |
| 66 | apoe3/3 | 5 |
| 67 | atv/r-treated | 5 |
| 68 | hydrocortisone-treated | 5 |
| 69 | l-carnitine-treated | 5 |
| 70 | lago | 5 |
| 71 | non-uraemic | 5 |
| 72 | nonshunted | 5 |
| 73 | oadm | 5 |
| 74 | ontarget/transcend | 5 |
| 75 | rescate-ii | 5 |
| 76 | terbinafine-treated | 5 |
| 77 | turks | 5 |
| 78 | venda | 5 |
| 79 | 1,325 | 4 |
| 80 | 3,057 | 4 |
| 81 | 3,583 | 4 |
| 82 | 33,357 | 4 |
| 83 | 5436 | 4 |
| 84 | 9664 | 4 |
| 85 | admire-hf | 4 |
| 86 | asenapine-treated | 4 |
| 87 | call-up | 4 |
| 88 | cyp2c9*1/*13 | 4 |
| 89 | garasiya | 4 |
| 90 | hatg-treated | 4 |
| 91 | high-bp | 4 |
| 92 | high-renin | 4 |
| 93 | kashmiri | 4 |
| 94 | krabbes | 4 |
| 95 | non-mfs | 4 |
| 96 | non-sarcopenia | 4 |
| 97 | ottawa-five | 4 |
| 98 | pdt-naive | 4 |
| 99 | pemetrexed-treated | 4 |
| 100 | pompholyx | 4 |
| 101 | psychoeducated | 4 |
| 102 | rbx-treated | 4 |
| 103 | rlx-treated | 4 |
| 104 | saigon | 4 |
| 105 | sibutramine-treated | 4 |
| 106 | tok | 4 |
| 107 | vegfr-tki-intolerant | 4 |
| 108 | 17,201 | 3 |
| 109 | 18,645 | 3 |
| 110 | 2,226 | 3 |
| 111 | 2,802 | 3 |
| 112 | 3,329 | 3 |
| 113 | 3852 | 3 |
| 114 | 5030 | 3 |
| 115 | 67,888 | 3 |
| 116 | 7,129 | 3 |
| 117 | 7,840 | 3 |
| 118 | 7485 | 3 |
| 119 | 9,856 | 3 |
| 120 | 9297 | 3 |
| 121 | ainu | 3 |
| 122 | ana-positive | 3 |
| 123 | anastrozole-treated | 3 |
| 124 | anti-tnf-ir | 3 |
| 125 | aqueous-il | 3 |
| 126 | b16-arg/arg | 3 |
| 127 | blindsight | 3 |
| 128 | cpap-naive | 3 |
| 129 | dabigatran-allocated | 3 |
| 130 | dd+ii | 3 |
| 131 | efp-group | 3 |
| 132 | er-to-er | 3 |
| 133 | eta-treated | 3 |
| 134 | fes-treated | 3 |
| 135 | french-canadians | 3 |
| 136 | glycine-treated | 3 |
| 137 | gt1b | 3 |
| 138 | guepard | 3 |
| 139 | hcv/hiv-coinfected | 3 |
| 140 | higher-educated | 3 |
| 141 | hiv-hbv-coinfected | 3 |
| 142 | hla-dr1/4 | 3 |
| 143 | influenza-confirmed | 3 |
| 144 | interferon-naive | 3 |
| 145 | iron-reduction | 3 |
| 146 | isradipine-treated | 3 |
| 147 | lercanidipine-treated | 3 |
| 148 | marker-negative | 3 |
| 149 | microbiologically-valid | 3 |
| 150 | mmf/srl-treated | 3 |
| 151 | non-eradicated | 3 |
| 152 | non-hfpef | 3 |
| 153 | non-hydrops | 3 |
| 154 | non-vad | 3 |
| 155 | nontransplantation | 3 |
| 156 | npm1+/flt3-itd- | 3 |
| 157 | nvp-treated | 3 |
| 158 | pastureland | 3 |
| 159 | pneumocystis-uninfected | 3 |
| 160 | policosanol-treated | 3 |
| 161 | post-oesophagectomy | 3 |
| 162 | pseudo-unipolar | 3 |
| 163 | pyuria-negative | 3 |
| 164 | quinidine-treated | 3 |
| 165 | reangiographed | 3 |
| 166 | reduced-obese | 3 |
| 167 | rpee | 3 |
| 168 | sdd-treated | 3 |
| 169 | septuagenarian | 3 |
| 170 | sln-negative | 3 |
| 171 | sotatercept-treated | 3 |
| 172 | spinal-cord-injured | 3 |
| 173 | subgroup-type | 3 |
| 174 | thienopyridine-treated | 3 |
| 175 | ventilator-independent | 3 |
| 176 | warfarin-allocated | 3 |
| 177 | wheelchairbound | 3 |
| 178 | yoruba-speaking | 3 |
| 179 | youngster | 3 |
| 180 | 1,294 | 2 |
| 181 | 1,941 | 2 |
| 182 | 10,688 | 2 |
| 183 | 10,880 | 2 |
| 184 | 10,939 | 2 |
| 185 | 102,050 | 2 |
| 186 | 12,522 | 2 |
| 187 | 15,067 | 2 |
| 188 | 153,180 | 2 |
| 189 | 154,942 | 2 |
| 190 | 17,263 | 2 |
| 191 | 2,245 | 2 |
| 192 | 2,246 | 2 |
| 193 | 2,282 | 2 |
| 194 | 2,817 | 2 |
| 195 | 2,944 | 2 |
| 196 | 2-ethylazaarenes | 2 |
| 197 | 25,709 | 2 |
| 198 | 2593 | 2 |
| 199 | 28,771 | 2 |
| 200 | 3,166 | 2 |
| 201 | 32,311 | 2 |
| 202 | 34,016 | 2 |
| 203 | 3782 | 2 |
| 204 | 4,502 | 2 |
| 205 | 4,576 | 2 |
| 206 | 4,964 | 2 |
| 207 | 4067 | 2 |
| 208 | 4201 | 2 |
| 209 | 4491 | 2 |
| 210 | 4494 | 2 |
| 211 | 4728 | 2 |
| 212 | 4894 | 2 |
| 213 | 4913 | 2 |
| 214 | 5,420 | 2 |
| 215 | 5,520 | 2 |
| 216 | 5598 | 2 |
| 217 | 6,311 | 2 |
| 218 | 6,632 | 2 |
| 219 | 6839 | 2 |
| 220 | 7,295 | 2 |
| 221 | 7,338 | 2 |
| 222 | 7,677 | 2 |
| 223 | 7486 | 2 |
| 224 | 8101 | 2 |
| 225 | 819,777 | 2 |
| 226 | 8328 | 2 |
| 227 | 8442 | 2 |
| 228 | 8566 | 2 |
| 229 | 8807 | 2 |
| 230 | 9098 | 2 |
| 231 | 9190 | 2 |
| 232 | 9955 | 2 |
| 233 | adinazolam-treated | 2 |
| 234 | adult-older | 2 |
| 235 | advanced-care | 2 |
| 236 | ago-negative | 2 |
| 237 | ago-positive | 2 |
| 238 | aln-treated | 2 |
| 239 | amifostine-treated | 2 |
| 240 | amisulpride-treated | 2 |
| 241 | amoxycillin-treated | 2 |
| 242 | anistreplase-treated | 2 |
| 243 | apo-14-3-3σ | 2 |
| 244 | ara-treated | 2 |
| 245 | artesunate-treated | 2 |
| 246 | asa-treated | 2 |
| 247 | auranofin-treated | 2 |
| 248 | azeri | 2 |
| 249 | bimagrumab-treated | 2 |
| 250 | bobo | 2 |
| 251 | bp-ii-only | 2 |
| 252 | cakchiquel | 2 |
| 253 | cart-naïve | 2 |
| 254 | cefazolin-treated | 2 |
| 255 | clopidogrel-naïve | 2 |
| 256 | clz-resistant | 2 |
| 257 | colistin-treated | 2 |
| 258 | coping/placebo | 2 |
| 259 | cortico- | 2 |
| 260 | diacetylmorphine-maintained | 2 |
| 261 | dofetilide-treated | 2 |
| 262 | dulaglutide-treated | 2 |
| 263 | ederly | 2 |
| 264 | eldersmile | 2 |
| 265 | endarterectomy-treated | 2 |
| 266 | enprostil-treated | 2 |
| 267 | evbd-treated | 2 |
| 268 | fluconazole-treated | 2 |
| 269 | gerd-positive | 2 |
| 270 | gpr-alone | 2 |
| 271 | gyneco-obstetric | 2 |
| 272 | ha-treated | 2 |
| 273 | hbo2-treated | 2 |
| 274 | hdl-deficient | 2 |
| 275 | headache-prone | 2 |
| 276 | high-uti-risk | 2 |
| 277 | higher-ses | 2 |
| 278 | hiv-1+ | 2 |
| 279 | home-monitored | 2 |
| 280 | huc-msc-treated | 2 |
| 281 | hypogammaglobulinaemic | 2 |
| 282 | immunoglobulin-treated | 2 |
| 283 | intensively-treated | 2 |
| 284 | k-712-treated | 2 |
| 285 | labetalol-treated | 2 |
| 286 | laboratory-acclimated | 2 |
| 287 | low-altitude | 2 |
| 288 | ltp-treated | 2 |
| 289 | mannitol-treated | 2 |
| 290 | mipomersen-treated | 2 |
| 291 | mmf/cni-treated | 2 |
| 292 | mosaicplasty-treated | 2 |
| 293 | ncpap-adherent | 2 |
| 294 | neuroflo-treated | 2 |
| 295 | nimesulide-treated | 2 |
| 296 | no-bav | 2 |
| 297 | no-college | 2 |
| 298 | non-acromegalic | 2 |
| 299 | non-amusic | 2 |
| 300 | non-communicative | 2 |
| 301 | non-intensive-pathway | 2 |
| 302 | non-laryngectomised | 2 |
| 303 | non-seminoma | 2 |
| 304 | nondrained | 2 |
| 305 | nonschizophrenic | 2 |
| 306 | normosensitive | 2 |
| 307 | ntx-treated | 2 |
| 308 | office-working | 2 |
| 309 | ospemifene-treated | 2 |
| 310 | ox-treated | 2 |
| 311 | pbt-pac | 2 |
| 312 | pirenzepine-treated | 2 |
| 313 | plerixafor-treated | 2 |
| 314 | post-bariatric-surgery | 2 |
| 315 | prehospital-treated | 2 |
| 316 | psycho-traumatised | 2 |
| 317 | qbg10-treated | 2 |
| 318 | repeat-biopsy | 2 |
| 319 | sas/iml | 2 |
| 320 | sci-crf | 2 |
| 321 | self-stigmatized | 2 |
| 322 | single-point-in-time | 2 |
| 323 | sship-ii | 2 |
| 324 | sssg-iss/fss | 2 |
| 325 | super-high-risk | 2 |
| 326 | tli-treated | 2 |
| 327 | tmjd-affected | 2 |
| 328 | trc-treated | 2 |
| 329 | treatment-eligible | 2 |
| 330 | tubu | 2 |
| 331 | ulbd-treated | 2 |
| 332 | ultrafiltration-treated | 2 |
| 333 | uti-susceptible | 2 |
| 334 | vasolabile | 2 |
| 335 | zoledronate-treated | 2 |
| 336 | 'unselected | 1 |
| 337 | 1-ketamine-injection | 1 |
| 338 | 10,186 | 1 |
| 339 | 10,234 | 1 |
| 340 | 10,532 | 1 |
| 341 | 10,611 | 1 |
| 342 | 10300 | 1 |
| 343 | 104,750 | 1 |
| 344 | 108,118 | 1 |
| 345 | 11,671 | 1 |
| 346 | 11-324 | 1 |
| 347 | 110,484 | 1 |
| 348 | 11483 | 1 |
| 349 | 12'133 | 1 |
| 350 | 12,513 | 1 |
| 351 | 12,768 | 1 |
| 352 | 126,571 | 1 |
| 353 | 13,858 | 1 |
| 354 | 13,885 | 1 |
| 355 | 14,349 | 1 |
| 356 | 15,059 | 1 |
| 357 | 15,254 | 1 |
| 358 | 15,295 | 1 |
| 359 | 15,318 | 1 |
| 360 | 16,176 | 1 |
| 361 | 16,603 | 1 |
| 362 | 17,850 | 1 |
| 363 | 170,143 | 1 |
| 364 | 17150 | 1 |
| 365 | 174,573 | 1 |
| 366 | 18,889 | 1 |
| 367 | 19,719 | 1 |
| 368 | 19,925 | 1 |
| 369 | 20,388 | 1 |
| 370 | 20,856 | 1 |
| 371 | 20-70-year-old | 1 |
| 372 | 207,540 | 1 |
| 373 | 209,650 | 1 |
| 374 | 21,926 | 1 |
| 375 | 22,444 | 1 |
| 376 | 22,628 | 1 |
| 377 | 23,336 | 1 |
| 378 | 23,460 | 1 |
| 379 | 238dpn | 1 |
| 380 | 24,708 | 1 |
| 381 | 246,955 | 1 |
| 382 | 25,268 | 1 |
| 383 | 25,505 | 1 |
| 384 | 2528 | 1 |
| 385 | 256,827 | 1 |
| 386 | 26,180 | 1 |
| 387 | 28,200 | 1 |
| 388 | 29,805 | 1 |
| 389 | 3,661 | 1 |
| 390 | 3,696 | 1 |
| 391 | 3,940 | 1 |
| 392 | 30,295 | 1 |
| 393 | 30,595 | 1 |
| 394 | 303/2708 | 1 |
| 395 | 32,180 | 1 |
| 396 | 32,248 | 1 |
| 397 | 33,370 | 1 |
| 398 | 33,659 | 1 |
| 399 | 33/113 | 1 |
| 400 | 33953 | 1 |
| 401 | 34,820 | 1 |
| 402 | 356,222 | 1 |
| 403 | 367,294 | 1 |
| 404 | 37,345 | 1 |
| 405 | 37217 | 1 |
| 406 | 39,221 | 1 |
| 407 | 39,872 | 1 |
| 408 | 4,458 | 1 |
| 409 | 4,485 | 1 |
| 410 | 40543 | 1 |
| 411 | 41,267 | 1 |
| 412 | 42,292 | 1 |
| 413 | 4372 | 1 |
| 414 | 45,134 | 1 |
| 415 | 45,217 | 1 |
| 416 | 45,481 | 1 |
| 417 | 46,003 | 1 |
| 418 | 46,135 | 1 |
| 419 | 46,490 | 1 |
| 420 | 46,764 | 1 |
| 421 | 464,000 | 1 |
| 422 | 48,586 | 1 |
| 423 | 49,906 | 1 |
| 424 | 5,045 | 1 |
| 425 | 5-11-year-old | 1 |
| 426 | 5409 | 1 |
| 427 | 5566 | 1 |
| 428 | 56,044 | 1 |
| 429 | 5627 | 1 |
| 430 | 5661 | 1 |
| 431 | 5706 | 1 |
| 432 | 5835 | 1 |
| 433 | 59,995 | 1 |
| 434 | 6,179 | 1 |
| 435 | 6,752,655 | 1 |
| 436 | 6,795 | 1 |
| 437 | 6090 | 1 |
| 438 | 61,604 | 1 |
| 439 | 62605 | 1 |
| 440 | 65,001 | 1 |
| 441 | 6908 | 1 |
| 442 | 7,062 | 1 |
| 443 | 7,376 | 1 |
| 444 | 7099 | 1 |
| 445 | 71,108 | 1 |
| 446 | 7265 | 1 |
| 447 | 73,299 | 1 |
| 448 | 7362 | 1 |
| 449 | 7409 | 1 |
| 450 | 7431 | 1 |
| 451 | 8,281 | 1 |
| 452 | 8,700,000 | 1 |
| 453 | 80,144 | 1 |
| 454 | 80,375 | 1 |
| 455 | 81,176 | 1 |
| 456 | 81,867 | 1 |
| 457 | 82,142 | 1 |
| 458 | 8363 | 1 |
| 459 | 8494 | 1 |
| 460 | 8592 | 1 |
| 461 | 87,635 | 1 |
| 462 | 8mop-treated | 1 |
| 463 | 9,189 | 1 |
| 464 | 9,312 | 1 |
| 465 | 9,449 | 1 |
| 466 | 9,518 | 1 |
| 467 | 9,588 | 1 |
| 468 | 9,835 | 1 |
| 469 | 91,080 | 1 |
| 470 | 91,388 | 1 |
| 471 | 9155 | 1 |
| 472 | 9262 | 1 |
| 473 | 95,808 | 1 |
| 474 | 99,278 | 1 |
| 475 | 9922 | 1 |
| 476 | a1at-deficient | 1 |
| 477 | add-on-treated | 1 |
| 478 | adhd-alone | 1 |
| 479 | aebm-treated | 1 |
| 480 | alc-treated | 1 |
| 481 | alirocumab-treated | 1 |
| 482 | allantoxanamide-induced | 1 |
| 483 | alloxa-induced | 1 |
| 484 | anemia-prone | 1 |
| 485 | anticonvulsant-treated | 1 |
| 486 | ape1-negative | 1 |
| 487 | arm-c | 1 |
| 488 | autogenic-training | 1 |
| 489 | awori | 1 |
| 490 | b2/b2 | 1 |
| 491 | bakweri | 1 |
| 492 | benuaq | 1 |
| 493 | bisacodyl-treated | 1 |
| 494 | brace-treated | 1 |
| 495 | brca1-positive | 1 |
| 496 | breast-engorged | 1 |
| 497 | bt563-treated | 1 |
| 498 | buserelin-treated | 1 |
| 499 | ca153+/3144+ | 1 |
| 500 | can+ | 1 |
| 501 | can- | 1 |
| 502 | captopril-tested | 1 |
| 503 | carbohydrate-treated | 1 |
| 504 | chlorhexidine-treated | 1 |
| 505 | cilazapril-treated | 1 |
| 506 | context.chf | 1 |
| 507 | coumarin-treated | 1 |
| 508 | cryo-biopsy | 1 |
| 509 | ct-planned | 1 |
| 510 | depot-treated | 1 |
| 511 | dfp-treated | 1 |
| 512 | disorder.enrolled | 1 |
| 513 | dmd-treated | 1 |
| 514 | dnr-treated | 1 |
| 515 | dsa-treated | 1 |
| 516 | early-reconstructed | 1 |
| 517 | ecg-appropriate | 1 |
| 518 | ecs-treated | 1 |
| 519 | effects-reduced | 1 |
| 520 | endocrine-only-treated | 1 |
| 521 | epc-treated | 1 |
| 522 | etas-treated | 1 |
| 523 | etidronate-treated | 1 |
| 524 | exposure-to-secondhand | 1 |
| 525 | fc225-treated | 1 |
| 526 | fh-positive | 1 |
| 527 | flosequinan-treated | 1 |
| 528 | flu-treated | 1 |
| 529 | fobt-positive | 1 |
| 530 | furazolidone/ort-treated | 1 |
| 531 | ghimbi | 1 |
| 532 | glue-treated | 1 |
| 533 | ha-irinotecan-treated | 1 |
| 534 | haida | 1 |
| 535 | hbv/hdv-infected | 1 |
| 536 | hcv-treated | 1 |
| 537 | high-guilt | 1 |
| 538 | high-otr | 1 |
| 539 | hla-a*02-positive | 1 |
| 540 | hsv2-positive | 1 |
| 541 | i131-treated | 1 |
| 542 | iaa+ | 1 |
| 543 | ima-treated | 1 |
| 544 | imp3-negative | 1 |
| 545 | indigeneous | 1 |
| 546 | individuals-a | 1 |
| 547 | ioxaglate-treated | 1 |
| 548 | ivatan | 1 |
| 549 | ketorolac-premedicated | 1 |
| 550 | korowai | 1 |
| 551 | kurd | 1 |
| 552 | l-t4-treated | 1 |
| 553 | laboratory-exposed | 1 |
| 554 | lestaurtinib-treated | 1 |
| 555 | mel-treated | 1 |
| 556 | melperone-treated | 1 |
| 557 | men-which | 1 |
| 558 | midazolam-plr1-negative | 1 |
| 559 | midazolam-plr1-positive | 1 |
| 560 | middle-aged-to-elderly | 1 |
| 561 | mizo | 1 |
| 562 | mogct | 1 |
| 563 | mppt-treated | 1 |
| 564 | nalmefene-treated | 1 |
| 565 | ncep-classified | 1 |
| 566 | neutron-treated | 1 |
| 567 | nevirapine-naïve | 1 |
| 568 | nitrendipine-treated | 1 |
| 569 | non-aitd | 1 |
| 570 | non-apathetic | 1 |
| 571 | non-beta-blocker-treated | 1 |
| 572 | non-lvsd | 1 |
| 573 | non-seizure-free | 1 |
| 574 | non-steroid-treated | 1 |
| 575 | non-turbinectomized | 1 |
| 576 | nonendarterectomized | 1 |
| 577 | nonhypomagnesemic | 1 |
| 578 | nonmeditating | 1 |
| 579 | nonpostpartum-depressed | 1 |
| 580 | nonrecovered | 1 |
| 581 | nonruminant | 1 |
| 582 | normal-urination | 1 |
| 583 | ojibway-anishinabe | 1 |
| 584 | oncourological | 1 |
| 585 | op-1–treated | 1 |
| 586 | pancreatic/stepped | 1 |
| 587 | patients.high | 1 |
| 588 | patients.traditional | 1 |
| 589 | pei-treated | 1 |
| 590 | pf-treated | 1 |
| 591 | pharmaceuticalcare | 1 |
| 592 | pimecrolimus-treated | 1 |
| 593 | placebo-retreated | 1 |
| 594 | prm-treated | 1 |
| 595 | probiotics-treated | 1 |
| 596 | propofol-plr1-negative | 1 |
| 597 | propofol-plr1-positive | 1 |
| 598 | pvc-managed | 1 |
| 599 | rhepo-treated | 1 |
| 600 | rls-affected | 1 |
| 601 | rva-paced | 1 |
| 602 | santali | 1 |
| 603 | sdzchh380-treated | 1 |
| 604 | serum-activated | 1 |
| 605 | sham-labeled | 1 |
| 606 | sit-treated | 1 |
| 607 | smi+ | 1 |
| 608 | smi- | 1 |
| 609 | stavudine-treated | 1 |
| 610 | steroid-treatment | 1 |
| 611 | stpg-treated | 1 |
| 612 | study.156 | 1 |
| 613 | study.912 | 1 |
| 614 | subanen | 1 |
| 615 | support-group | 1 |
| 616 | teg-monitored | 1 |
| 617 | tg-undetectable | 1 |
| 618 | thakali | 1 |
| 619 | thiopental/isoflurane-treated | 1 |
| 620 | ticarcillin-treated | 1 |
| 621 | tns-treated | 1 |
| 622 | turbinectomized | 1 |
| 623 | uft-treated | 1 |
| 624 | ultrasound-treated | 1 |
| 625 | um-x7.1 | 1 |
| 626 | uncategorised | 1 |
| 627 | vehicle-and | 1 |
| 628 | verum-fed | 1 |
| 629 | voglibose-treated | 1 |
| 630 | vv-treated | 1 |
| 631 | wheelchair-using | 1 |
| 632 | whole-study | 1 |
| 633 | zidovudine-treated | 1 |
| 634 | βdg-positive | 1 |
| 1 | 'unselected | 1 |
| 2 | 1,294 | 2 |
| 3 | 1,325 | 4 |
| 4 | 1,414 | 7 |
| 5 | 1,941 | 2 |
| 6 | 1-ketamine-injection | 1 |
| 7 | 10,186 | 1 |
| 8 | 10,234 | 1 |
| 9 | 10,532 | 1 |
| 10 | 10,611 | 1 |
| 11 | 10,688 | 2 |
| 12 | 10,880 | 2 |
| 13 | 10,939 | 2 |
| 14 | 102,050 | 2 |
| 15 | 10300 | 1 |
| 16 | 104,750 | 1 |
| 17 | 108,118 | 1 |
| 18 | 11,671 | 1 |
| 19 | 11-324 | 1 |
| 20 | 110,484 | 1 |
| 21 | 11483 | 1 |
| 22 | 12'133 | 1 |
| 23 | 12,513 | 1 |
| 24 | 12,522 | 2 |
| 25 | 12,768 | 1 |
| 26 | 126,571 | 1 |
| 27 | 13,858 | 1 |
| 28 | 13,885 | 1 |
| 29 | 14,349 | 1 |
| 30 | 15,059 | 1 |
| 31 | 15,067 | 2 |
| 32 | 15,254 | 1 |
| 33 | 15,295 | 1 |
| 34 | 15,318 | 1 |
| 35 | 153,180 | 2 |
| 36 | 154,942 | 2 |
| 37 | 16,176 | 1 |
| 38 | 16,603 | 1 |
| 39 | 17,201 | 3 |
| 40 | 17,263 | 2 |
| 41 | 17,850 | 1 |
| 42 | 170,143 | 1 |
| 43 | 17150 | 1 |
| 44 | 174,573 | 1 |
| 45 | 1757 | 7 |
| 46 | 18,645 | 3 |
| 47 | 18,889 | 1 |
| 48 | 19,719 | 1 |
| 49 | 19,925 | 1 |
| 50 | 1905 | 20 |
| 51 | 2,226 | 3 |
| 52 | 2,245 | 2 |
| 53 | 2,246 | 2 |
| 54 | 2,282 | 2 |
| 55 | 2,708 | 6 |
| 56 | 2,802 | 3 |
| 57 | 2,817 | 2 |
| 58 | 2,944 | 2 |
| 59 | 2-ethylazaarenes | 2 |
| 60 | 20,388 | 1 |
| 61 | 20,856 | 1 |
| 62 | 20-70-year-old | 1 |
| 63 | 207,540 | 1 |
| 64 | 209,650 | 1 |
| 65 | 21,926 | 1 |
| 66 | 22,444 | 1 |
| 67 | 22,628 | 1 |
| 68 | 23,336 | 1 |
| 69 | 23,460 | 1 |
| 70 | 238dpn | 1 |
| 71 | 24,708 | 1 |
| 72 | 246,955 | 1 |
| 73 | 25,268 | 1 |
| 74 | 25,505 | 1 |
| 75 | 25,709 | 2 |
| 76 | 2528 | 1 |
| 77 | 256,827 | 1 |
| 78 | 2593 | 2 |
| 79 | 26,180 | 1 |
| 80 | 2636 | 7 |
| 81 | 28,200 | 1 |
| 82 | 28,771 | 2 |
| 83 | 29,805 | 1 |
| 84 | 3,057 | 4 |
| 85 | 3,166 | 2 |
| 86 | 3,329 | 3 |
| 87 | 3,583 | 4 |
| 88 | 3,661 | 1 |
| 89 | 3,696 | 1 |
| 90 | 3,940 | 1 |
| 91 | 30,295 | 1 |
| 92 | 30,595 | 1 |
| 93 | 303/2708 | 1 |
| 94 | 3117 | 7 |
| 95 | 32,180 | 1 |
| 96 | 32,248 | 1 |
| 97 | 32,311 | 2 |
| 98 | 33,357 | 4 |
| 99 | 33,370 | 1 |
| 100 | 33,659 | 1 |
| 101 | 33/113 | 1 |
| 102 | 33953 | 1 |
| 103 | 34,016 | 2 |
| 104 | 34,820 | 1 |
| 105 | 356,222 | 1 |
| 106 | 367,294 | 1 |
| 107 | 37,345 | 1 |
| 108 | 37217 | 1 |
| 109 | 3782 | 2 |
| 110 | 3852 | 3 |
| 111 | 39,221 | 1 |
| 112 | 39,872 | 1 |
| 113 | 4,458 | 1 |
| 114 | 4,485 | 1 |
| 115 | 4,502 | 2 |
| 116 | 4,576 | 2 |
| 117 | 4,964 | 2 |
| 118 | 40543 | 1 |
| 119 | 4067 | 2 |
| 120 | 41,267 | 1 |
| 121 | 42,292 | 1 |
| 122 | 4201 | 2 |
| 123 | 4372 | 1 |
| 124 | 4491 | 2 |
| 125 | 4494 | 2 |
| 126 | 45,134 | 1 |
| 127 | 45,217 | 1 |
| 128 | 45,481 | 1 |
| 129 | 46,003 | 1 |
| 130 | 46,135 | 1 |
| 131 | 46,490 | 1 |
| 132 | 46,764 | 1 |
| 133 | 464,000 | 1 |
| 134 | 4728 | 2 |
| 135 | 48,586 | 1 |
| 136 | 4888 | 5 |
| 137 | 4894 | 2 |
| 138 | 49,906 | 1 |
| 139 | 4913 | 2 |
| 140 | 5,045 | 1 |
| 141 | 5,420 | 2 |
| 142 | 5,520 | 2 |
| 143 | 5-11-year-old | 1 |
| 144 | 5010 | 10 |
| 145 | 5030 | 3 |
| 146 | 5409 | 1 |
| 147 | 5436 | 4 |
| 148 | 5566 | 1 |
| 149 | 5598 | 2 |
| 150 | 56,044 | 1 |
| 151 | 5627 | 1 |
| 152 | 5661 | 1 |
| 153 | 5706 | 1 |
| 154 | 5835 | 1 |
| 155 | 59,995 | 1 |
| 156 | 6,179 | 1 |
| 157 | 6,311 | 2 |
| 158 | 6,632 | 2 |
| 159 | 6,752,655 | 1 |
| 160 | 6,795 | 1 |
| 161 | 6090 | 1 |
| 162 | 61,604 | 1 |
| 163 | 62605 | 1 |
| 164 | 65,001 | 1 |
| 165 | 6632 | 9 |
| 166 | 67,888 | 3 |
| 167 | 6797 | 5 |
| 168 | 6839 | 2 |
| 169 | 6908 | 1 |
| 170 | 7,062 | 1 |
| 171 | 7,129 | 3 |
| 172 | 7,295 | 2 |
| 173 | 7,338 | 2 |
| 174 | 7,376 | 1 |
| 175 | 7,677 | 2 |
| 176 | 7,840 | 3 |
| 177 | 7099 | 1 |
| 178 | 71,108 | 1 |
| 179 | 7265 | 1 |
| 180 | 73,299 | 1 |
| 181 | 7362 | 1 |
| 182 | 7409 | 1 |
| 183 | 7431 | 1 |
| 184 | 7485 | 3 |
| 185 | 7486 | 2 |
| 186 | 7788 | 11 |
| 187 | 8,281 | 1 |
| 188 | 8,700,000 | 1 |
| 189 | 80,144 | 1 |
| 190 | 80,375 | 1 |
| 191 | 81,176 | 1 |
| 192 | 81,867 | 1 |
| 193 | 8101 | 2 |
| 194 | 819,777 | 2 |
| 195 | 82,142 | 1 |
| 196 | 8328 | 2 |
| 197 | 8363 | 1 |
| 198 | 8442 | 2 |
| 199 | 8494 | 1 |
| 200 | 8566 | 2 |
| 201 | 8592 | 1 |
| 202 | 87,635 | 1 |
| 203 | 8807 | 2 |
| 204 | 8mop-treated | 1 |
| 205 | 9,189 | 1 |
| 206 | 9,312 | 1 |
| 207 | 9,449 | 1 |
| 208 | 9,518 | 1 |
| 209 | 9,588 | 1 |
| 210 | 9,835 | 1 |
| 211 | 9,856 | 3 |
| 212 | 9098 | 2 |
| 213 | 91,080 | 1 |
| 214 | 91,388 | 1 |
| 215 | 9155 | 1 |
| 216 | 9190 | 2 |
| 217 | 9262 | 1 |
| 218 | 9297 | 3 |
| 219 | 95,808 | 1 |
| 220 | 9664 | 4 |
| 221 | 99,278 | 1 |
| 222 | 9922 | 1 |
| 223 | 9955 | 2 |
| 224 | a1at-deficient | 1 |
| 225 | acarbose-treated | 5 |
| 226 | acei-treated | 11 |
| 227 | acrf | 5 |
| 228 | add-on-treated | 1 |
| 229 | adenosine-treated | 7 |
| 230 | adhd-alone | 1 |
| 231 | adinazolam-treated | 2 |
| 232 | admire-hf | 4 |
| 233 | adult-older | 2 |
| 234 | advanced-care | 2 |
| 235 | aebm-treated | 1 |
| 236 | ago-negative | 2 |
| 237 | ago-positive | 2 |
| 238 | ainu | 3 |
| 239 | alc-treated | 1 |
| 240 | alirocumab-treated | 1 |
| 241 | allantoxanamide-induced | 1 |
| 242 | alloxa-induced | 1 |
| 243 | aln-treated | 2 |
| 244 | amifostine-treated | 2 |
| 245 | amisulpride-treated | 2 |
| 246 | amoxycillin-treated | 2 |
| 247 | amusic | 5 |
| 248 | ana-positive | 3 |
| 249 | anastrozole-treated | 3 |
| 250 | anemia-prone | 1 |
| 251 | anistreplase-treated | 2 |
| 252 | anti-tnf-ir | 3 |
| 253 | anticonvulsant-treated | 1 |
| 254 | ape1-negative | 1 |
| 255 | apo-14-3-3σ | 2 |
| 256 | apoe3/3 | 5 |
| 257 | aqueous-il | 3 |
| 258 | ara-treated | 2 |
| 259 | arm-c | 1 |
| 260 | arten | 7 |
| 261 | artesunate-treated | 2 |
| 262 | asa-treated | 2 |
| 263 | asenapine-treated | 4 |
| 264 | atv/r-treated | 5 |
| 265 | auranofin-treated | 2 |
| 266 | autogenic-training | 1 |
| 267 | awori | 1 |
| 268 | azeri | 2 |
| 269 | b16-arg/arg | 3 |
| 270 | b2/b2 | 1 |
| 271 | bakweri | 1 |
| 272 | benuaq | 1 |
| 273 | bimagrumab-treated | 2 |
| 274 | biomarker-positive | 26 |
| 275 | bisacodyl-treated | 1 |
| 276 | blindsight | 3 |
| 277 | bobo | 2 |
| 278 | bp-ii-only | 2 |
| 279 | brace-treated | 1 |
| 280 | brca1-positive | 1 |
| 281 | breast-engorged | 1 |
| 282 | briakinumab-treated | 6 |
| 283 | brunei | 6 |
| 284 | bt563-treated | 1 |
| 285 | buserelin-treated | 1 |
| 286 | ca153+/3144+ | 1 |
| 287 | cakchiquel | 2 |
| 288 | call-up | 4 |
| 289 | can+ | 1 |
| 290 | can- | 1 |
| 291 | captopril-tested | 1 |
| 292 | carbohydrate-treated | 1 |
| 293 | cart-naïve | 2 |
| 294 | cefazolin-treated | 2 |
| 295 | cefixime-treated | 10 |
| 296 | chlorhexidine-treated | 1 |
| 297 | cilazapril-treated | 1 |
| 298 | cimetidine-treated | 6 |
| 299 | claudicant | 10 |
| 300 | clomipramine-treated | 6 |
| 301 | clopidogrel-naïve | 2 |
| 302 | clz-resistant | 2 |
| 303 | colistin-treated | 2 |
| 304 | context.chf | 1 |
| 305 | coping/placebo | 2 |
| 306 | cortico- | 2 |
| 307 | coumarin-treated | 1 |
| 308 | cpap-naive | 3 |
| 309 | cryo-biopsy | 1 |
| 310 | ct-planned | 1 |
| 311 | cyp2c9*1/*13 | 4 |
| 312 | cyp2c9*1/*3 | 21 |
| 313 | dabigatran-allocated | 3 |
| 314 | dd+ii | 3 |
| 315 | depot-treated | 1 |
| 316 | dfp-treated | 1 |
| 317 | diacetylmorphine-maintained | 2 |
| 318 | dislipidemic | 6 |
| 319 | disorder.enrolled | 1 |
| 320 | dmd-treated | 1 |
| 321 | dnr-treated | 1 |
| 322 | dofetilide-treated | 2 |
| 323 | dsa-treated | 1 |
| 324 | dulaglutide-treated | 2 |
| 325 | early-reconstructed | 1 |
| 326 | ecg-appropriate | 1 |
| 327 | ecs-treated | 1 |
| 328 | ederly | 2 |
| 329 | effects-reduced | 1 |
| 330 | efficacy-evaluable | 8 |
| 331 | efficacy-valid | 9 |
| 332 | efp-group | 3 |
| 333 | elder | 149 |
| 334 | elderly | 12,925 |
| 335 | eldersmile | 2 |
| 336 | endarterectomy-treated | 2 |
| 337 | endocrine-only-treated | 1 |
| 338 | enprostil-treated | 2 |
| 339 | epc-treated | 1 |
| 340 | er-to-er | 3 |
| 341 | eta-treated | 3 |
| 342 | etas-treated | 1 |
| 343 | etidronate-treated | 1 |
| 344 | evbd-treated | 2 |
| 345 | experimental-group | 6 |
| 346 | exposure-to-secondhand | 1 |
| 347 | fc225-treated | 1 |
| 348 | fe-scz | 15 |
| 349 | fes-treated | 3 |
| 350 | fh-positive | 1 |
| 351 | flosequinan-treated | 1 |
| 352 | flu-treated | 1 |
| 353 | fluconazole-treated | 2 |
| 354 | fobt-positive | 1 |
| 355 | french-canadians | 3 |
| 356 | furazolidone/ort-treated | 1 |
| 357 | garasiya | 4 |
| 358 | gerd-positive | 2 |
| 359 | ghimbi | 1 |
| 360 | glucosafe | 7 |
| 361 | glue-treated | 1 |
| 362 | glycine-treated | 3 |
| 363 | gpr-alone | 2 |
| 364 | gt1b | 3 |
| 365 | guepard | 3 |
| 366 | gyneco-obstetric | 2 |
| 367 | ha-irinotecan-treated | 1 |
| 368 | ha-treated | 2 |
| 369 | haida | 1 |
| 370 | hatg-treated | 4 |
| 371 | hbo2-treated | 2 |
| 372 | hbv/hdv-infected | 1 |
| 373 | hcv-treated | 1 |
| 374 | hcv/hiv-coinfected | 3 |
| 375 | hdl-deficient | 2 |
| 376 | headache-prone | 2 |
| 377 | high-bp | 4 |
| 378 | high-guilt | 1 |
| 379 | high-otr | 1 |
| 380 | high-renin | 4 |
| 381 | high-uti-risk | 2 |
| 382 | higher-educated | 3 |
| 383 | higher-ses | 2 |
| 384 | hiv-1+ | 2 |
| 385 | hiv-hbv-coinfected | 3 |
| 386 | hiv/tuberculosis | 10 |
| 387 | hla-a*02-positive | 1 |
| 388 | hla-dr1/4 | 3 |
| 389 | home-monitored | 2 |
| 390 | hsv2-positive | 1 |
| 391 | huc-msc-treated | 2 |
| 392 | hydrocortisone-treated | 5 |
| 393 | hyperfiltering | 9 |
| 394 | hypogammaglobulinaemic | 2 |
| 395 | i131-treated | 1 |
| 396 | iaa+ | 1 |
| 397 | ima-treated | 1 |
| 398 | immuno-competent | 7 |
| 399 | immunoglobulin-treated | 2 |
| 400 | imp3-negative | 1 |
| 401 | indigeneous | 1 |
| 402 | individuals-a | 1 |
| 403 | influenza-confirmed | 3 |
| 404 | intensively-treated | 2 |
| 405 | interferon-naive | 3 |
| 406 | ioxaglate-treated | 1 |
| 407 | iron-reduction | 3 |
| 408 | iron-treated | 9 |
| 409 | isradipine-treated | 3 |
| 410 | ivatan | 1 |
| 411 | k-712-treated | 2 |
| 412 | kashmiri | 4 |
| 413 | ketorolac-premedicated | 1 |
| 414 | korowai | 1 |
| 415 | krabbes | 4 |
| 416 | kurd | 1 |
| 417 | l-carnitine-treated | 5 |
| 418 | l-t4-treated | 1 |
| 419 | labetalol-treated | 2 |
| 420 | laboratory-acclimated | 2 |
| 421 | laboratory-exposed | 1 |
| 422 | lago | 5 |
| 423 | lercanidipine-treated | 3 |
| 424 | lestaurtinib-treated | 1 |
| 425 | loracarbef-treated | 15 |
| 426 | low-altitude | 2 |
| 427 | ltp-treated | 2 |
| 428 | macau | 10 |
| 429 | mannitol-treated | 2 |
| 430 | marker-negative | 3 |
| 431 | mel-treated | 1 |
| 432 | melperone-treated | 1 |
| 433 | men-which | 1 |
| 434 | microbiologically-valid | 3 |
| 435 | midazolam-plr1-negative | 1 |
| 436 | midazolam-plr1-positive | 1 |
| 437 | middle-aged-to-elderly | 1 |
| 438 | milnacipran-treated | 10 |
| 439 | mipomersen-treated | 2 |
| 440 | mizo | 1 |
| 441 | mmf/cni-treated | 2 |
| 442 | mmf/srl-treated | 3 |
| 443 | mogct | 1 |
| 444 | mosaicplasty-treated | 2 |
| 445 | mppt-treated | 1 |
| 446 | multitrauma | 8 |
| 447 | nalmefene-treated | 1 |
| 448 | ncep-classified | 1 |
| 449 | ncpap-adherent | 2 |
| 450 | neuroflo-treated | 2 |
| 451 | neutron-treated | 1 |
| 452 | nevirapine-naïve | 1 |
| 453 | nimesulide-treated | 2 |
| 454 | nitrendipine-treated | 1 |
| 455 | no-bav | 2 |
| 456 | no-college | 2 |
| 457 | non-acromegalic | 2 |
| 458 | non-aitd | 1 |
| 459 | non-amusic | 2 |
| 460 | non-apathetic | 1 |
| 461 | non-beta-blocker-treated | 1 |
| 462 | non-communicative | 2 |
| 463 | non-eradicated | 3 |
| 464 | non-hfpef | 3 |
| 465 | non-hydrops | 3 |
| 466 | non-intensive-pathway | 2 |
| 467 | non-laryngectomised | 2 |
| 468 | non-lvsd | 1 |
| 469 | non-mfs | 4 |
| 470 | non-sarcopenia | 4 |
| 471 | non-seizure-free | 1 |
| 472 | non-seminoma | 2 |
| 473 | non-steroid-treated | 1 |
| 474 | non-svr | 13 |
| 475 | non-turbinectomized | 1 |
| 476 | non-uraemic | 5 |
| 477 | non-vad | 3 |
| 478 | nondrained | 2 |
| 479 | nonendarterectomized | 1 |
| 480 | nonhypomagnesemic | 1 |
| 481 | nonmeditating | 1 |
| 482 | nonpaced | 7 |
| 483 | nonpostpartum-depressed | 1 |
| 484 | nonrecovered | 1 |
| 485 | nonruminant | 1 |
| 486 | nonschizophrenic | 2 |
| 487 | nonshunted | 5 |
| 488 | nontransplantation | 3 |
| 489 | normal-urination | 1 |
| 490 | normosensitive | 2 |
| 491 | npm1+/flt3-itd- | 3 |
| 492 | ntx-treated | 2 |
| 493 | nvp-treated | 3 |
| 494 | oadm | 5 |
| 495 | octogenarian | 27 |
| 496 | office-working | 2 |
| 497 | ofloxacin-treated | 7 |
| 498 | ojibway-anishinabe | 1 |
| 499 | oldest-old | 24 |
| 500 | oncourological | 1 |
| 501 | ontarget/transcend | 5 |
| 502 | op-1–treated | 1 |
| 503 | ospemifene-treated | 2 |
| 504 | ottawa-five | 4 |
| 505 | ox-treated | 2 |
| 506 | pancreatic/stepped | 1 |
| 507 | parkfit | 9 |
| 508 | pastureland | 3 |
| 509 | patients.high | 1 |
| 510 | patients.traditional | 1 |
| 511 | pbt-pac | 2 |
| 512 | pdt-naive | 4 |
| 513 | pediatric/adolescent | 6 |
| 514 | pei-treated | 1 |
| 515 | pemetrexed-treated | 4 |
| 516 | pf-treated | 1 |
| 517 | pharmaceuticalcare | 1 |
| 518 | pimecrolimus-treated | 1 |
| 519 | pirenzepine-treated | 2 |
| 520 | placebo-retreated | 1 |
| 521 | plerixafor-treated | 2 |
| 522 | pneumocystis-uninfected | 3 |
| 523 | policosanol-treated | 3 |
| 524 | polydipsic | 7 |
| 525 | pompholyx | 4 |
| 526 | post-bariatric-surgery | 2 |
| 527 | post-menarchal | 7 |
| 528 | post-oesophagectomy | 3 |
| 529 | prehospital-treated | 2 |
| 530 | prm-treated | 1 |
| 531 | probiotics-treated | 1 |
| 532 | propofol-plr1-negative | 1 |
| 533 | propofol-plr1-positive | 1 |
| 534 | pseudo-unipolar | 3 |
| 535 | psycho-traumatised | 2 |
| 536 | psychoeducated | 4 |
| 537 | pvc-managed | 1 |
| 538 | pyuria-negative | 3 |
| 539 | qbg10-treated | 2 |
| 540 | quetiapine-treated | 17 |
| 541 | quinidine-treated | 3 |
| 542 | rbx-treated | 4 |
| 543 | reangiographed | 3 |
| 544 | reduced-obese | 3 |
| 545 | repeat-biopsy | 2 |
| 546 | rescate-ii | 5 |
| 547 | response-evaluable | 7 |
| 548 | rfviia-treated | 9 |
| 549 | rhepo-treated | 1 |
| 550 | risedronate-treated | 10 |
| 551 | rls-affected | 1 |
| 552 | rlx-treated | 4 |
| 553 | rmd+ | 7 |
| 554 | rpee | 3 |
| 555 | rva-paced | 1 |
| 556 | saigon | 4 |
| 557 | santali | 1 |
| 558 | sas/iml | 2 |
| 559 | sci-crf | 2 |
| 560 | sdd-treated | 3 |
| 561 | sdzchh380-treated | 1 |
| 562 | self-stigmatized | 2 |
| 563 | septuagenarian | 3 |
| 564 | serum-activated | 1 |
| 565 | sham-labeled | 1 |
| 566 | shangaans | 6 |
| 567 | sibutramine-treated | 4 |
| 568 | single-point-in-time | 2 |
| 569 | sit-treated | 1 |
| 570 | sln-negative | 3 |
| 571 | smi+ | 1 |
| 572 | smi- | 1 |
| 573 | sotatercept-treated | 3 |
| 574 | spinal-cord-injured | 3 |
| 575 | sship-ii | 2 |
| 576 | sssg-iss/fss | 2 |
| 577 | stavudine-treated | 1 |
| 578 | stdrx | 8 |
| 579 | steroid-treatment | 1 |
| 580 | stpg-treated | 1 |
| 581 | streptokinase-treated | 9 |
| 582 | study.156 | 1 |
| 583 | study.912 | 1 |
| 584 | subanen | 1 |
| 585 | subgroup-type | 3 |
| 586 | super-high-risk | 2 |
| 587 | superobese | 35 |
| 588 | support-group | 1 |
| 589 | tamoxifen-treated | 54 |
| 590 | teg-monitored | 1 |
| 591 | terbinafine-treated | 5 |
| 592 | tg-undetectable | 1 |
| 593 | thakali | 1 |
| 594 | thienopyridine-treated | 3 |
| 595 | thiopental/isoflurane-treated | 1 |
| 596 | ticarcillin-treated | 1 |
| 597 | tli-treated | 2 |
| 598 | tmjd-affected | 2 |
| 599 | tns-treated | 1 |
| 600 | tok | 4 |
| 601 | trc-treated | 2 |
| 602 | treatment-adherent | 9 |
| 603 | treatment-eligible | 2 |
| 604 | tubu | 2 |
| 605 | turbinectomized | 1 |
| 606 | turks | 5 |
| 607 | tx/is | 6 |
| 608 | uft-treated | 1 |
| 609 | ulbd-treated | 2 |
| 610 | ultrafiltration-treated | 2 |
| 611 | ultrasound-treated | 1 |
| 612 | um-x7.1 | 1 |
| 613 | uncategorised | 1 |
| 614 | uti-susceptible | 2 |
| 615 | vasolabile | 2 |
| 616 | vegfr-tki-intolerant | 4 |
| 617 | vehicle-and | 1 |
| 618 | venda | 5 |
| 619 | ventilator-independent | 3 |
| 620 | verum-fed | 1 |
| 621 | vka-naive | 15 |
| 622 | voglibose-treated | 1 |
| 623 | vpa-treated | 7 |
| 624 | vv-treated | 1 |
| 625 | warfarin-allocated | 3 |
| 626 | wheelchair-using | 1 |
| 627 | wheelchairbound | 3 |
| 628 | whole-study | 1 |
| 629 | yoruba-speaking | 3 |
| 630 | youngster | 3 |
| 631 | zaïre | 7 |
| 632 | zidovudine-treated | 1 |
| 633 | zoledronate-treated | 2 |
| 634 | βdg-positive | 1 |
| 1 | hiv-1+ | 2 |
| 2 | ca153+/3144+ | 1 |
| 3 | iaa+ | 1 |
| 4 | rmd+ | 7 |
| 5 | smi+ | 1 |
| 6 | can+ | 1 |
| 7 | npm1+/flt3-itd- | 3 |
| 8 | smi- | 1 |
| 9 | can- | 1 |
| 10 | cortico- | 2 |
| 11 | 8,700,000 | 1 |
| 12 | 464,000 | 1 |
| 13 | 28,200 | 1 |
| 14 | 10300 | 1 |
| 15 | 5010 | 10 |
| 16 | 5,420 | 2 |
| 17 | 5,520 | 2 |
| 18 | 34,820 | 1 |
| 19 | 5030 | 3 |
| 20 | 207,540 | 1 |
| 21 | 7,840 | 3 |
| 22 | 3,940 | 1 |
| 23 | 102,050 | 2 |
| 24 | 17150 | 1 |
| 25 | 209,650 | 1 |
| 26 | 104,750 | 1 |
| 27 | 17,850 | 1 |
| 28 | 23,460 | 1 |
| 29 | 33,370 | 1 |
| 30 | 91,080 | 1 |
| 31 | 32,180 | 1 |
| 32 | 153,180 | 2 |
| 33 | 26,180 | 1 |
| 34 | 10,880 | 2 |
| 35 | 6090 | 1 |
| 36 | 9190 | 2 |
| 37 | 46,490 | 1 |
| 38 | um-x7.1 | 1 |
| 39 | 65,001 | 1 |
| 40 | 8101 | 2 |
| 41 | 17,201 | 3 |
| 42 | 4201 | 2 |
| 43 | 32,311 | 2 |
| 44 | 6,311 | 2 |
| 45 | 10,611 | 1 |
| 46 | 39,221 | 1 |
| 47 | 7431 | 1 |
| 48 | 1,941 | 2 |
| 49 | 3,661 | 1 |
| 50 | 5661 | 1 |
| 51 | 126,571 | 1 |
| 52 | 11,671 | 1 |
| 53 | 28,771 | 2 |
| 54 | 8,281 | 1 |
| 55 | 45,481 | 1 |
| 56 | 4491 | 2 |
| 57 | 4,502 | 2 |
| 58 | 2,802 | 3 |
| 59 | 9,312 | 1 |
| 60 | study.912 | 1 |
| 61 | 356,222 | 1 |
| 62 | 12,522 | 2 |
| 63 | 9922 | 1 |
| 64 | 10,532 | 1 |
| 65 | 6,632 | 2 |
| 66 | 6632 | 9 |
| 67 | 82,142 | 1 |
| 68 | 8442 | 2 |
| 69 | 154,942 | 2 |
| 70 | 3852 | 3 |
| 71 | 7,062 | 1 |
| 72 | 9262 | 1 |
| 73 | 7362 | 1 |
| 74 | 4372 | 1 |
| 75 | 39,872 | 1 |
| 76 | 2,282 | 2 |
| 77 | 3782 | 2 |
| 78 | 42,292 | 1 |
| 79 | 8592 | 1 |
| 80 | b2/b2 | 1 |
| 81 | cyp2c9*1/*3 | 21 |
| 82 | apoe3/3 | 5 |
| 83 | 46,003 | 1 |
| 84 | 16,603 | 1 |
| 85 | cyp2c9*1/*13 | 4 |
| 86 | 33/113 | 1 |
| 87 | 12,513 | 1 |
| 88 | 4913 | 2 |
| 89 | 12'133 | 1 |
| 90 | 170,143 | 1 |
| 91 | 40543 | 1 |
| 92 | 33953 | 1 |
| 93 | 17,263 | 2 |
| 94 | 8363 | 1 |
| 95 | 174,573 | 1 |
| 96 | 11483 | 1 |
| 97 | 3,583 | 4 |
| 98 | 2593 | 2 |
| 99 | hla-dr1/4 | 3 |
| 100 | 61,604 | 1 |
| 101 | 1,414 | 7 |
| 102 | 11-324 | 1 |
| 103 | 45,134 | 1 |
| 104 | 10,234 | 1 |
| 105 | 56,044 | 1 |
| 106 | 80,144 | 1 |
| 107 | 22,444 | 1 |
| 108 | 2,944 | 2 |
| 109 | 15,254 | 1 |
| 110 | 9664 | 4 |
| 111 | 46,764 | 1 |
| 112 | 4,964 | 2 |
| 113 | 110,484 | 1 |
| 114 | 1,294 | 2 |
| 115 | 367,294 | 1 |
| 116 | 4494 | 2 |
| 117 | 8494 | 1 |
| 118 | 4894 | 2 |
| 119 | 25,505 | 1 |
| 120 | 62605 | 1 |
| 121 | 29,805 | 1 |
| 122 | 1905 | 20 |
| 123 | 1,325 | 4 |
| 124 | 19,925 | 1 |
| 125 | 46,135 | 1 |
| 126 | 87,635 | 1 |
| 127 | 9,835 | 1 |
| 128 | 5835 | 1 |
| 129 | 5,045 | 1 |
| 130 | 2,245 | 2 |
| 131 | 37,345 | 1 |
| 132 | 18,645 | 3 |
| 133 | 9155 | 1 |
| 134 | 6,752,655 | 1 |
| 135 | 246,955 | 1 |
| 136 | 9955 | 2 |
| 137 | 7265 | 1 |
| 138 | 80,375 | 1 |
| 139 | 4,485 | 1 |
| 140 | 7485 | 3 |
| 141 | 13,885 | 1 |
| 142 | 30,295 | 1 |
| 143 | 15,295 | 1 |
| 144 | 7,295 | 2 |
| 145 | 30,595 | 1 |
| 146 | 6,795 | 1 |
| 147 | 59,995 | 1 |
| 148 | 5706 | 1 |
| 149 | 49,906 | 1 |
| 150 | 34,016 | 2 |
| 151 | 2,226 | 3 |
| 152 | 21,926 | 1 |
| 153 | 23,336 | 1 |
| 154 | 5436 | 4 |
| 155 | 2636 | 7 |
| 156 | 2,246 | 2 |
| 157 | study.156 | 1 |
| 158 | 20,856 | 1 |
| 159 | 9,856 | 3 |
| 160 | 3,166 | 2 |
| 161 | 5566 | 1 |
| 162 | 8566 | 2 |
| 163 | 81,176 | 1 |
| 164 | 16,176 | 1 |
| 165 | 7,376 | 1 |
| 166 | 4,576 | 2 |
| 167 | 10,186 | 1 |
| 168 | 7486 | 2 |
| 169 | 48,586 | 1 |
| 170 | 3,696 | 1 |
| 171 | 8807 | 2 |
| 172 | 3117 | 7 |
| 173 | 45,217 | 1 |
| 174 | 37217 | 1 |
| 175 | 2,817 | 2 |
| 176 | 5627 | 1 |
| 177 | 256,827 | 1 |
| 178 | 3,057 | 4 |
| 179 | 33,357 | 4 |
| 180 | 1757 | 7 |
| 181 | 15,067 | 2 |
| 182 | 4067 | 2 |
| 183 | 41,267 | 1 |
| 184 | 81,867 | 1 |
| 185 | 7,677 | 2 |
| 186 | 819,777 | 2 |
| 187 | 9297 | 3 |
| 188 | 6797 | 5 |
| 189 | 71,108 | 1 |
| 190 | 2,708 | 6 |
| 191 | 24,708 | 1 |
| 192 | 303/2708 | 1 |
| 193 | 95,808 | 1 |
| 194 | 6908 | 1 |
| 195 | 108,118 | 1 |
| 196 | 15,318 | 1 |
| 197 | 9,518 | 1 |
| 198 | 8328 | 2 |
| 199 | 2528 | 1 |
| 200 | 22,628 | 1 |
| 201 | 4728 | 2 |
| 202 | 7,338 | 2 |
| 203 | 32,248 | 1 |
| 204 | 4,458 | 1 |
| 205 | 13,858 | 1 |
| 206 | 25,268 | 1 |
| 207 | 12,768 | 1 |
| 208 | 99,278 | 1 |
| 209 | 20,388 | 1 |
| 210 | 91,388 | 1 |
| 211 | 9,588 | 1 |
| 212 | 10,688 | 2 |
| 213 | 7788 | 11 |
| 214 | 67,888 | 3 |
| 215 | 4888 | 5 |
| 216 | 9098 | 2 |
| 217 | 5598 | 2 |
| 218 | 5409 | 1 |
| 219 | 7409 | 1 |
| 220 | 25,709 | 2 |
| 221 | 19,719 | 1 |
| 222 | 7,129 | 3 |
| 223 | 3,329 | 3 |
| 224 | 6839 | 2 |
| 225 | 10,939 | 2 |
| 226 | 14,349 | 1 |
| 227 | 9,449 | 1 |
| 228 | 15,059 | 1 |
| 229 | 33,659 | 1 |
| 230 | 6,179 | 1 |
| 231 | 9,189 | 1 |
| 232 | 18,889 | 1 |
| 233 | 7099 | 1 |
| 234 | 73,299 | 1 |
| 235 | individuals-a | 1 |
| 236 | haida | 1 |
| 237 | venda | 5 |
| 238 | non-sarcopenia | 4 |
| 239 | non-seminoma | 2 |
| 240 | multitrauma | 8 |
| 241 | garasiya | 4 |
| 242 | gt1b | 3 |
| 243 | arm-c | 1 |
| 244 | pbt-pac | 2 |
| 245 | non-acromegalic | 2 |
| 246 | hypogammaglobulinaemic | 2 |
| 247 | non-uraemic | 5 |
| 248 | dislipidemic | 6 |
| 249 | nonhypomagnesemic | 1 |
| 250 | nonschizophrenic | 2 |
| 251 | gyneco-obstetric | 2 |
| 252 | polydipsic | 7 |
| 253 | amusic | 5 |
| 254 | non-amusic | 2 |
| 255 | non-apathetic | 1 |
| 256 | non-vad | 3 |
| 257 | rva-paced | 1 |
| 258 | nonpaced | 7 |
| 259 | effects-reduced | 1 |
| 260 | alloxa-induced | 1 |
| 261 | allantoxanamide-induced | 1 |
| 262 | verum-fed | 1 |
| 263 | pvc-managed | 1 |
| 264 | breast-engorged | 1 |
| 265 | reangiographed | 3 |
| 266 | ncep-classified | 1 |
| 267 | sham-labeled | 1 |
| 268 | disorder.enrolled | 1 |
| 269 | influenza-confirmed | 3 |
| 270 | nondrained | 2 |
| 271 | diacetylmorphine-maintained | 2 |
| 272 | ct-planned | 1 |
| 273 | pancreatic/stepped | 1 |
| 274 | nonrecovered | 1 |
| 275 | home-monitored | 2 |
| 276 | teg-monitored | 1 |
| 277 | spinal-cord-injured | 3 |
| 278 | non-laryngectomised | 2 |
| 279 | uncategorised | 1 |
| 280 | psycho-traumatised | 2 |
| 281 | laboratory-exposed | 1 |
| 282 | nonpostpartum-depressed | 1 |
| 283 | non-eradicated | 3 |
| 284 | ketorolac-premedicated | 1 |
| 285 | dabigatran-allocated | 3 |
| 286 | warfarin-allocated | 3 |
| 287 | higher-educated | 3 |
| 288 | psychoeducated | 4 |
| 289 | qbg10-treated | 2 |
| 290 | sdzchh380-treated | 1 |
| 291 | i131-treated | 1 |
| 292 | k-712-treated | 2 |
| 293 | hbo2-treated | 2 |
| 294 | bt563-treated | 1 |
| 295 | l-t4-treated | 1 |
| 296 | fc225-treated | 1 |
| 297 | ha-treated | 2 |
| 298 | rfviia-treated | 9 |
| 299 | ima-treated | 1 |
| 300 | vpa-treated | 7 |
| 301 | ara-treated | 2 |
| 302 | asa-treated | 2 |
| 303 | dsa-treated | 1 |
| 304 | eta-treated | 3 |
| 305 | alirocumab-treated | 1 |
| 306 | briakinumab-treated | 6 |
| 307 | bimagrumab-treated | 2 |
| 308 | lestaurtinib-treated | 1 |
| 309 | alc-treated | 1 |
| 310 | epc-treated | 1 |
| 311 | trc-treated | 2 |
| 312 | huc-msc-treated | 2 |
| 313 | ulbd-treated | 2 |
| 314 | evbd-treated | 2 |
| 315 | sdd-treated | 3 |
| 316 | pemetrexed-treated | 4 |
| 317 | non-steroid-treated | 1 |
| 318 | dmd-treated | 1 |
| 319 | ultrasound-treated | 1 |
| 320 | brace-treated | 1 |
| 321 | dofetilide-treated | 2 |
| 322 | nimesulide-treated | 2 |
| 323 | amisulpride-treated | 2 |
| 324 | dulaglutide-treated | 2 |
| 325 | fluconazole-treated | 2 |
| 326 | anastrozole-treated | 3 |
| 327 | cefixime-treated | 10 |
| 328 | thiopental/isoflurane-treated | 1 |
| 329 | nalmefene-treated | 1 |
| 330 | ospemifene-treated | 2 |
| 331 | glycine-treated | 3 |
| 332 | quinidine-treated | 3 |
| 333 | thienopyridine-treated | 3 |
| 334 | cimetidine-treated | 6 |
| 335 | chlorhexidine-treated | 1 |
| 336 | stavudine-treated | 1 |
| 337 | zidovudine-treated | 1 |
| 338 | terbinafine-treated | 5 |
| 339 | clomipramine-treated | 6 |
| 340 | sibutramine-treated | 4 |
| 341 | quetiapine-treated | 17 |
| 342 | asenapine-treated | 4 |
| 343 | pirenzepine-treated | 2 |
| 344 | isradipine-treated | 3 |
| 345 | lercanidipine-treated | 3 |
| 346 | nitrendipine-treated | 1 |
| 347 | adenosine-treated | 7 |
| 348 | l-carnitine-treated | 5 |
| 349 | amifostine-treated | 2 |
| 350 | melperone-treated | 1 |
| 351 | hydrocortisone-treated | 5 |
| 352 | anistreplase-treated | 2 |
| 353 | streptokinase-treated | 9 |
| 354 | voglibose-treated | 1 |
| 355 | acarbose-treated | 5 |
| 356 | ioxaglate-treated | 1 |
| 357 | zoledronate-treated | 2 |
| 358 | risedronate-treated | 10 |
| 359 | etidronate-treated | 1 |
| 360 | artesunate-treated | 2 |
| 361 | carbohydrate-treated | 1 |
| 362 | glue-treated | 1 |
| 363 | loracarbef-treated | 15 |
| 364 | pf-treated | 1 |
| 365 | stpg-treated | 1 |
| 366 | hatg-treated | 4 |
| 367 | acei-treated | 11 |
| 368 | pei-treated | 1 |
| 369 | tli-treated | 2 |
| 370 | mmf/cni-treated | 2 |
| 371 | prehospital-treated | 2 |
| 372 | mel-treated | 1 |
| 373 | cilazapril-treated | 1 |
| 374 | enprostil-treated | 2 |
| 375 | labetalol-treated | 2 |
| 376 | policosanol-treated | 3 |
| 377 | mannitol-treated | 2 |
| 378 | mmf/srl-treated | 3 |
| 379 | bisacodyl-treated | 1 |
| 380 | adinazolam-treated | 2 |
| 381 | aebm-treated | 1 |
| 382 | prm-treated | 1 |
| 383 | ha-irinotecan-treated | 1 |
| 384 | flosequinan-treated | 1 |
| 385 | milnacipran-treated | 10 |
| 386 | tamoxifen-treated | 54 |
| 387 | mipomersen-treated | 2 |
| 388 | ofloxacin-treated | 7 |
| 389 | auranofin-treated | 2 |
| 390 | buserelin-treated | 1 |
| 391 | ticarcillin-treated | 1 |
| 392 | amoxycillin-treated | 2 |
| 393 | cefazolin-treated | 2 |
| 394 | immunoglobulin-treated | 2 |
| 395 | coumarin-treated | 1 |
| 396 | colistin-treated | 2 |
| 397 | aln-treated | 2 |
| 398 | add-on-treated | 1 |
| 399 | ultrafiltration-treated | 2 |
| 400 | iron-treated | 9 |
| 401 | neutron-treated | 1 |
| 402 | neuroflo-treated | 2 |
| 403 | rhepo-treated | 1 |
| 404 | dfp-treated | 1 |
| 405 | 8mop-treated | 1 |
| 406 | ltp-treated | 2 |
| 407 | nvp-treated | 3 |
| 408 | atv/r-treated | 5 |
| 409 | non-beta-blocker-treated | 1 |
| 410 | dnr-treated | 1 |
| 411 | plerixafor-treated | 2 |
| 412 | etas-treated | 1 |
| 413 | ecs-treated | 1 |
| 414 | probiotics-treated | 1 |
| 415 | fes-treated | 3 |
| 416 | tns-treated | 1 |
| 417 | pimecrolimus-treated | 1 |
| 418 | uft-treated | 1 |
| 419 | sit-treated | 1 |
| 420 | anticonvulsant-treated | 1 |
| 421 | depot-treated | 1 |
| 422 | sotatercept-treated | 3 |
| 423 | mppt-treated | 1 |
| 424 | furazolidone/ort-treated | 1 |
| 425 | flu-treated | 1 |
| 426 | hcv-treated | 1 |
| 427 | vv-treated | 1 |
| 428 | rbx-treated | 4 |
| 429 | rlx-treated | 4 |
| 430 | ox-treated | 2 |
| 431 | ntx-treated | 2 |
| 432 | intensively-treated | 2 |
| 433 | endocrine-only-treated | 1 |
| 434 | endarterectomy-treated | 2 |
| 435 | mosaicplasty-treated | 2 |
| 436 | placebo-retreated | 1 |
| 437 | op-1–treated | 1 |
| 438 | laboratory-acclimated | 2 |
| 439 | serum-activated | 1 |
| 440 | tmjd-affected | 2 |
| 441 | rls-affected | 1 |
| 442 | hbv/hdv-infected | 1 |
| 443 | pneumocystis-uninfected | 3 |
| 444 | hiv-hbv-coinfected | 3 |
| 445 | hcv/hiv-coinfected | 3 |
| 446 | 'unselected | 1 |
| 447 | early-reconstructed | 1 |
| 448 | nonshunted | 5 |
| 449 | captopril-tested | 1 |
| 450 | turbinectomized | 1 |
| 451 | non-turbinectomized | 1 |
| 452 | nonendarterectomized | 1 |
| 453 | self-stigmatized | 2 |
| 454 | efficacy-valid | 9 |
| 455 | microbiologically-valid | 3 |
| 456 | 20-70-year-old | 1 |
| 457 | 5-11-year-old | 1 |
| 458 | oldest-old | 24 |
| 459 | vehicle-and | 1 |
| 460 | exposure-to-secondhand | 1 |
| 461 | pastureland | 3 |
| 462 | ontarget/transcend | 5 |
| 463 | wheelchairbound | 3 |
| 464 | guepard | 3 |
| 465 | kurd | 1 |
| 466 | non-lvsd | 1 |
| 467 | non-aitd | 1 |
| 468 | ojibway-anishinabe | 1 |
| 469 | low-altitude | 2 |
| 470 | rpee | 3 |
| 471 | non-seizure-free | 1 |
| 472 | glucosafe | 7 |
| 473 | no-college | 2 |
| 474 | tg-undetectable | 1 |
| 475 | response-evaluable | 7 |
| 476 | efficacy-evaluable | 8 |
| 477 | treatment-eligible | 2 |
| 478 | uti-susceptible | 2 |
| 479 | vasolabile | 2 |
| 480 | eldersmile | 2 |
| 481 | single-point-in-time | 2 |
| 482 | adhd-alone | 1 |
| 483 | gpr-alone | 2 |
| 484 | anemia-prone | 1 |
| 485 | headache-prone | 2 |
| 486 | subgroup-type | 3 |
| 487 | advanced-care | 2 |
| 488 | pharmaceuticalcare | 1 |
| 489 | zaïre | 7 |
| 490 | reduced-obese | 3 |
| 491 | superobese | 35 |
| 492 | ecg-appropriate | 1 |
| 493 | vka-naive | 15 |
| 494 | interferon-naive | 3 |
| 495 | cpap-naive | 3 |
| 496 | pdt-naive | 4 |
| 497 | ottawa-five | 4 |
| 498 | non-communicative | 2 |
| 499 | ape1-negative | 1 |
| 500 | propofol-plr1-negative | 1 |
| 501 | midazolam-plr1-negative | 1 |
| 502 | imp3-negative | 1 |
| 503 | pyuria-negative | 3 |
| 504 | sln-negative | 3 |
| 505 | ago-negative | 2 |
| 506 | marker-negative | 3 |
| 507 | normosensitive | 2 |
| 508 | brca1-positive | 1 |
| 509 | propofol-plr1-positive | 1 |
| 510 | midazolam-plr1-positive | 1 |
| 511 | hla-a*02-positive | 1 |
| 512 | hsv2-positive | 1 |
| 513 | ana-positive | 3 |
| 514 | gerd-positive | 2 |
| 515 | βdg-positive | 1 |
| 516 | fh-positive | 1 |
| 517 | ago-positive | 2 |
| 518 | biomarker-positive | 26 |
| 519 | fobt-positive | 1 |
| 520 | nevirapine-naïve | 1 |
| 521 | clopidogrel-naïve | 2 |
| 522 | cart-naïve | 2 |
| 523 | non-hfpef | 3 |
| 524 | admire-hf | 4 |
| 525 | context.chf | 1 |
| 526 | sci-crf | 2 |
| 527 | acrf | 5 |
| 528 | yoruba-speaking | 3 |
| 529 | office-working | 2 |
| 530 | autogenic-training | 1 |
| 531 | hyperfiltering | 9 |
| 532 | wheelchair-using | 1 |
| 533 | nonmeditating | 1 |
| 534 | b16-arg/arg | 3 |
| 535 | men-which | 1 |
| 536 | patients.high | 1 |
| 537 | korowai | 1 |
| 538 | ghimbi | 1 |
| 539 | brunei | 6 |
| 540 | dd+ii | 3 |
| 541 | rescate-ii | 5 |
| 542 | sship-ii | 2 |
| 543 | thakali | 1 |
| 544 | santali | 1 |
| 545 | bakweri | 1 |
| 546 | azeri | 2 |
| 547 | kashmiri | 4 |
| 548 | awori | 1 |
| 549 | tok | 4 |
| 550 | super-high-risk | 2 |
| 551 | high-uti-risk | 2 |
| 552 | oncourological | 1 |
| 553 | post-menarchal | 7 |
| 554 | patients.traditional | 1 |
| 555 | cakchiquel | 2 |
| 556 | aqueous-il | 3 |
| 557 | sas/iml | 2 |
| 558 | oadm | 5 |
| 559 | septuagenarian | 3 |
| 560 | octogenarian | 27 |
| 561 | ivatan | 1 |
| 562 | subanen | 1 |
| 563 | arten | 7 |
| 564 | high-renin | 4 |
| 565 | saigon | 4 |
| 566 | normal-urination | 1 |
| 567 | nontransplantation | 3 |
| 568 | 1-ketamine-injection | 1 |
| 569 | iron-reduction | 3 |
| 570 | 238dpn | 1 |
| 571 | coping/placebo | 2 |
| 572 | bobo | 2 |
| 573 | lago | 5 |
| 574 | mizo | 1 |
| 575 | high-bp | 4 |
| 576 | call-up | 4 |
| 577 | experimental-group | 6 |
| 578 | efp-group | 3 |
| 579 | support-group | 1 |
| 580 | benuaq | 1 |
| 581 | pseudo-unipolar | 3 |
| 582 | er-to-er | 3 |
| 583 | elder | 149 |
| 584 | adult-older | 2 |
| 585 | youngster | 3 |
| 586 | anti-tnf-ir | 3 |
| 587 | high-otr | 1 |
| 588 | non-svr | 13 |
| 589 | krabbes | 4 |
| 590 | 2-ethylazaarenes | 2 |
| 591 | higher-ses | 2 |
| 592 | non-mfs | 4 |
| 593 | tx/is | 6 |
| 594 | hiv/tuberculosis | 10 |
| 595 | turks | 5 |
| 596 | shangaans | 6 |
| 597 | french-canadians | 3 |
| 598 | non-hydrops | 3 |
| 599 | sssg-iss/fss | 2 |
| 600 | indigeneous | 1 |
| 601 | mogct | 1 |
| 602 | blindsight | 3 |
| 603 | parkfit | 9 |
| 604 | high-guilt | 1 |
| 605 | claudicant | 10 |
| 606 | nonruminant | 1 |
| 607 | vegfr-tki-intolerant | 4 |
| 608 | clz-resistant | 2 |
| 609 | pediatric/adolescent | 6 |
| 610 | ventilator-independent | 3 |
| 611 | hdl-deficient | 2 |
| 612 | a1at-deficient | 1 |
| 613 | steroid-treatment | 1 |
| 614 | ncpap-adherent | 2 |
| 615 | treatment-adherent | 9 |
| 616 | immuno-competent | 7 |
| 617 | macau | 10 |
| 618 | tubu | 2 |
| 619 | ainu | 3 |
| 620 | no-bav | 2 |
| 621 | stdrx | 8 |
| 622 | pompholyx | 4 |
| 623 | non-intensive-pathway | 2 |
| 624 | whole-study | 1 |
| 625 | bp-ii-only | 2 |
| 626 | ederly | 2 |
| 627 | elderly | 12,925 |
| 628 | middle-aged-to-elderly | 1 |
| 629 | post-oesophagectomy | 3 |
| 630 | post-bariatric-surgery | 2 |
| 631 | cryo-biopsy | 1 |
| 632 | repeat-biopsy | 2 |
| 633 | fe-scz | 15 |
| 634 | apo-14-3-3σ | 2 |